Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids

计划入组 304 人 · 首次发布于 2022 年 4 月 27 日

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

首次发布于 2020 年 8 月 14 日

Construction of CITIC Xiangya Assisted Reproduction Data Repository

计划入组 119,590 人 · 首次发布于 2022 年 6 月 3 日

CITI-002

CITI-001

Allogeneic mesenchymal stem cells therapy(Novellus Therapeutics/NoveCite)

CITIESRISE

South Africa

Citius Pharmaceuticals

United States

CITIC Heavy Industries Co., Ltd.

China

Citius Pharmaceuticals Closes $15.8M Direct Offering to Fund LYMPHIR Commercial Launch

BridgeBio Pharma Receives Optimistic Buy Recommendation Amid Promising Drug Developments

Cipla Shares Surge as USFDA Greenlights Abraxane Generic Launch